Skip to content
Biotech ETFs in Focus episode artwork

Mar 8, 2016 55 min

Biotech ETFs in Focus

from ETF Prime

Brad Loncar, Head of Loncar Investments, joins us in studio to spotlight the index behind the Loncar Cancer Immunotherapy ETF (CNCR) and discuss the innovation occurring in cancer treatment. Nate and Conor also explain why ETFs can be an excellent way to access the biotech space in general.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Biotech ETFs in Focus

0:00 55:48

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of ETF Prime?

This episode is 55 minutes long.

When was this ETF Prime episode published?

This episode was published on March 8, 2016.

Can I download this ETF Prime episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.